Perrigo Sets Records For Quarterly, Annual Sales, ProfitsThe Allegan health and beauty products maker Perrigo Co. (Nasdaq: PRGO) reported record sales and net income for the fourth fiscal quarter and fiscal year ended June 29.
Perrigo Reports Record Second Quarter Revenue, Higher ProfitThe Allegan generic drugmaker Perrigo Co. Friday record revenue of $883 million for its second fiscal quarter ended Dec. 29, up from $838.2 million in the same quarter a year earlier. Net income for the quarter was $106 million or $1.12 a share, up from $99.7 million or $1.06 aa share in the same quarter a year earlier.
Perrigo Sales, Profits Both Jump 15 Percent For Fiscal YearThe generic drug and store-brand health and beauty products maker Perrigo Co. (Nasdaq: PRGO) Thursday reported net income fo $393 million or $4.18 a share in its fiscal year ended June 30, up 15 percent from $340.6 million or $3.64 a share in the prior fiscal year.
Perrigo Launches Morphine After FDA ApprovalThe Allegan-based health and beauty products manufacturer Perrigo Co. (Nasdaq: PRGO) said Wednesday it has received final approval from the United States Food and Drug Administration for its abbreviated new drug application for morphine sulfate 100ml/5 percent oral solution.
Perrigo Reports Record Revenue, Profit For Fiscal YearAllegan-based Perrigo Co. reported record revenue of $2.76 billion for its fiscal year ended June 25, up 21 percent or $487 million from $2.27 billion a year earlier.
Perrigo Reports Record Quarterly Revenue and Earnings, Raises Full Year GuidanceThe Allegan generic drug and health and beauty supplies maker Perrigo Co. (Nasdaq: PRGO) reported record revenue of $691.6 million in its third fiscal quarter ended March 26, up from $537.6 million in the same quarter a year earlier. Net income was $91.5 million or 98 cents a share, up from $61.5 million or 66 cents a share in the same quarter of the prior fiscal year.
Perrigo Company Announces Quarterly DividendAllegan-based Perrigo Co. Thursday announced that its board of directors declared a quarterly dividend of 7 cents a share.
Perrigo Posts Record Revenue and Earnings, Raises GuidanceThe Allegan generic drug and store brand health and beauty products maker Perrigo Co. Tuesday reported sharply higher sales and revenue for its second fiscal quarter and six months, ended Dec. 25.